Background and Purpose
In the US, about half of acute ischemic stroke patients treated with tissue plasminogen activator (tPA) receive treatment within 60 minutes of hospital arrival. We aimed to determine the proportion of patients receiving tPA within 60 minutes (DTNT≤60) and 45 minutes (DTNT≤45) of hospital arrival by race/ethnicity and sex and to identify temporal trends in DTNT≤60 and DTNT≤45.
Methods
Among 65,654 AIS admissions in the NINDS-funded FL-PR Collaboration to Reduce Stroke Disparities (CReSD) Study from 2010–2015, we included 6,181 IV tPA-treated cases (9.4%). Generalized estimating equations were used to determine predictors of DTNT≤60 and DTNT≤45.
Results
DTNT≤60 was achieved in 42% and DTNT≤45 in 18% of cases. After adjustment, women less likely received DTNT≤60 (OR=0.81, 95% CI 0.72–0.92) and DTNT≤45 (OR=0.73 95% CI 0.57–0.93). Compared to whites, Blacks less likely had DTNT≤45 during off hours (OR= 0.68, 95% CI 0.47–0.98). Achievement of DTNT≤60 and DTNT≤45 was highest in South Florida (50%, 23%) and lowest in West Central Florida (28%, 11%).
Conclusions
In the FL-PR Collaboration to Reduce Stroke Disparities, achievement of DTNT≤60 and DTNT≤45 remains low. Compared to Whites, Blacks less likely receive tPA treatment within 45 minutes during off hours. Treatment within 60 and 45 minutes is lower in women compared to men and lowest in West Central Florida compared to other Florida regions and Puerto Rico. Further research is needed to identify reasons for delayed thrombolytic treatment in women and Blacks and factors contributing to regional disparities in DTNT.